| Phospholipid oxidation and carotenoid supplementation in Alzheimer's disease patients [ahead of print] |
Ademowo OS, Dias HK, Milic I, Dervitt A, Moran R, Mulcahy R, Howard AN, Nolan JM, Griffiths HR |
2017 |
| Plasma Lutein and Zeaxanthin Are Associated With Better Cognitive Function Across Multiple Domains in a Large Population-Based Sample of Older Adults: Findings from The Irish Longitudinal Study on Aging. |
Feeney J, O'Leary N, Moran R, O'Halloran AM, Nolan JM, Beatty S, Young IS, Kenny RA. |
2017 |
| Serum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT) |
Kelly D, Nolan JM, Howard AN, Stack J, Akuffo KO, Moran R, Thurnham DI, Dennison J, Meagher KA, Beatty S |
2017 |
| The evidence informing the surgeon’s selection of intraocular lens on the basis of light transmittance properties |
Li X, Kelly D, Nolan JM, Dennison JL, Beatty S |
2017 |
|
Author Response: Comments on Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: CREST - Report 1: Retina, 2016
|
John Nolan, Rebecca Power, Jim Stringham, Jessica Dennison, Jim Stack David Kelly, Rachel Moran, Kwadwo Akuffo, Laura Corcoran, S Beatty |
2016 |
|
Bone and Landrum: Comments on Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: CREST - Report 1: Retina, 2016
|
Bone and Landrum |
2016 |
|
Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: Central Retinal Enrichment Supplementation Trials – Report 1
|
John Nolan, Rebecca Power, Jim Stringham, Jessica Dennison, Jim Stack David Kelly, Rachel Moran, Kwadwo Akuffo, Laura Corcoran, S Beatty |
2016 |
|
Quantification of zeaxanthin stereoisomers and lutein in trout flesh using chiral high-performance liquid chromatography-diode array detection
|
Alfonso Prado-Cabrero, Stephen Beatty, Jim Stack, Alan Howard, John M. Nolan |
2016 |
|
Macular Supplements Containing Zinc and Vitamin A Should Be Replaced with Meso-Zeaxanthin, Lutein and Zeaxanthin: An Ophthalmic Need for Pharmacovigilance
|
Amber Hoang, Michael S Tolentino and Michael J Tolentino |
2016 |
|
Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density
|
Le Ma, Rong Liu, Jun Hui Du, Tao Liu, Shan Shan Wu and Xiao Hong Liu |
2016 |
|
An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases
|
Roxanne Crosby Nwaobi Philip Hykin Tunde Peto Sobha Sivaprasad |
2016 |
|
Non-dietary correlates and determinants of plasma lutein and zeaxanthin concentrations in the Irish population
|
R Moran, JM Nolan, J Stack, A.M O'Halloran, J Feeney, K.O Akuffo, R.A Kenny and S Beatty. |
2016 |
|
Relationship between macular pigment and visual function in subjects with early age-related macular degeneration
|
Kwadwo Owusu Akuffo, John M Nolan, Tunde Peto, Jim Stack, Irene Leung, Laura Corcoran, Stephen Beatty |
2016 |
| Antitumor activity of meso-zeaxanthine and its mechanism of action |
Firdous A. P., Binitha P. P, Girija Kuttan, Ramadasan Kuttan |
2016 |
|
Lutein, zeaxanthin and meso-zeaxanthin content of eggs laid by hens supplemented with free and esterified xanthophylls
|
John M. Nolan Katherine A. Meagher Alan N. Howard, Rachel Moran, David I. Thurnham and Stephen Beatty |
2016 |
|
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
|
Nicole K. Scripsema, Dan-Ning Hu and Richard B. Rosen |
2015 |
|
Concordance of Macular Pigment Measurement Using Customized Heterochromatic Flicker Photometry and Fundus Autofluorescence in Age-Related Macular Degeneration
|
Kwadwo Owusu Akuffo,Stephen Beatty, Jim Stack, Tunde Peto, Irene Leung, Laura Corcoran, Rebecca Power, and John M. Nolan |
2015 |
|
Visual Function and Its Relationship with Severity of Early, and Activity of Neovascular, Age-Related Macular Degeneration.
|
Loughman, S Sabour-Pickett, JM Nolan, B Klein, R Klein. J |
2015 |
|
Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease
|
Bernstein PS, Li B, Vachali PP, Gorusupudi A, Shyam R, Henriksen BS, Nolan JM. |
2015 |
|
Assessment of lutein, zeaxanthin and meso-zeaxanthin concentrations in dietary supplements by chiral high-performance liquid chromatography
|
Alfonso Prado‑Cabrero, Stephen Beatty, Alan Howard, Jim Stack, Philipp Bettin, John M. Nolan |
2015 |
|
Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids
|
David Kelly Robert F. Coen, Kwadwo Owusu Akuffo, Stephen Beatty, Jessica Dennison, Rachel Moran, Jim Stack, Alan N. Howard, Riona Mulcahy an |
2015 |
|
Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration
|
KO Akuffo, JM Nolan, AN Howard, R Moran, J Stack, R Klein, BE Klein, SM Meuer, S Sabour-Pickett, DI Thurnham and S Beatty |
2015 |
| Anti-inflammatory potential of carotenoid meso-zeaxanthin and its mode of action. |
Firdous AP, Kuttan G, Kuttan R. |
2015 |
|
Prevalence of age-related macular degeneration in the Republic of Ireland
|
Kwadwo Owusu Akuffo,John Nolan, Jim Stack, Rachel Moran, Joanne Feeney, Rose Anne Kenny, Tunde Peto, Cara Dooley, Aisling M O’Halloran, Hila |
2015 |
|
The Impact of Supplemental Macular Carotenoids in Alzheimer’s Disease: A Randomized Clinical Trial [ahead of print]
|
Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham D, Beatty |
2014 |
| Regarding Macular Xanthophylls and ω-3 Long-Chain Polyunsaturated Fatty Acids in Age-Related Macular Degeneration |
Meagher KA, Nolan JM, Beatty, S. |
2014 |
|
Macular Response to supplementation with differing xanthophyll formulations in subjects with and without age related macular degeneration
|
Thurnham DI, Nolan JM, Howard AN, Beatty S |
2014 |
|
Verification of Meso-Zeaxanthin in Fish
|
Nolan JM, Beatty S, Meagher K, Howard AN, Kelly D, Thurnham DI |
2014 |
|
Supplementation with three different macular carotenoid formulations inpatients with early age-related macular degeneration
|
Sabour-Pickett S1, Beatty S, Connolly E, Loughman J, Stack J, Howard A, Klein R, Klein BE, Meuer SM, Myers CE, Akuffo KO, Nolan JM |
2014 |
|
Central Retinal Enrichment Supplementation Trials (CREST): Design and Methodology of the CREST Randomized Controlled Trials.
|
Akuffo KO1, Beatty S, Stack J, Dennison J, O'Regan S, Meagher KA, Peto T, Nolan J. |
2014 |
|
Macular Pigment, Visual Function, and Macular Disease among Subjects with Alzheimer's Disease: An Exploratory Study
|
John Nolan Nolan JM, Loskutova E, Howard AN, Moran R, Mulcahy R, Stack J, Bolger M, Dennison J, Akuffo KO, Owens N, Thurnham DI, Beatty S |
2014 |
|
Syngene Toxicology Capabilities
|
Syngene International Limited (Sponsored by IOSA) |
2014 |
|
Syngene Corporate Presentation
|
Syngene International Limited (Sponsored by IOSA) |
2014 |
|
90-Day Repeated Dose Toxicity Study of 40:60 Diacetate Lutein: Diacetate Meso-Zeaxanthin by Oral Gavage in Sprague Dawley Rats
|
Syngene International Limited (Sponsored by IOSA) |
2014 |
|
Evidence for Including Lutein and Zeaxanthin in Oral Supplements for Age Related Macular Degeneration
|
Musch DC |
2013 |
|
AREDS2: what does it mean for eye care?
|
Nolan JM, Beatty S, Stack J |
2013 |
|
Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age Related Macular Degeneration Progression
|
The Age-Related Eye Disease Study 2 (AREDS2) Research |
2013 |
|
LuteinZeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
|
The Age-Related Eye Disease Study 2 (AREDS2) Research Group* |
2013 |
|
Enhancing Performance While Avoiding Damage: A Contribution of Macular Pigment
|
Stringham J and Snodderly M |
2013 |
|
Studies on meso-zeaxanthin for potential toxicity and mutagenicity
|
Thurnham, D and Howard AN |
2013 |
|
Anticarcinogenic activity of meso-zeaxanthin in rodents and its possible mechanism of action
|
Alikkunjhi Pararikkal Firdousa, Edakkadath Raghavan Sindhua, Viswanathan Ramnathb & Ramadasan Kuttan |
2013 |
|
Macular Pigment and Its Contribution to Vision
|
Ekaterina Loskutova, John Nolan, Alan Howard and Stephen Beatty |
2013 |
|
What is meso-zeaxanthin, and where does it come from?
|
J M Nolan, K Meagher, S Kashani and S Beatty |
2013 |
|
Safety evaluation of meso-zeaxanthin
|
Xinde Xu , Lihua Zhang, Bin Shao, Xiaoxia Sun, Chi-Tang Ho, Shiming Li b |
2013 |
|
Nutrient reference values for bioactives: new approaches needed? A conference report
|
Hans Konrad Biesalski, John W. Erdman, Jr., John Hathcock,corresponding author Kathleen Ellwood, Stephen Beatty, Elizabeth Johnson, Roberto |
2013 |
|
Achieving visual excellence through optimization of macular pigment
|
Kashani, S, Nolan , JM and Beatty. S |
2013 |
|
Impact of Macular Pigment on Visual Performance
|
Dennison, J, Nolan, JM, Beatty, S and O'Regan, G |
2012 |
|
Secondary Outcomes in a Clinical Trial of Carotenoids with Coantioxidants versus Placebo in Early Age-Related Macular Degeneration
|
Beatty S, Chakravarthy U, Nolan JM, Muldrew KA, Woodside JV, Denny F, Stevenson MR |
2012 |
| Profiles of macular pigment optical density and their changes following supplemental lutein and zeaxannthin |
Nolan J, Beatty S |
2012 |
| Impact of dietary carotenoid deprivation on macular pigment and serum concentrations of lutein and zeaxanthin |
Loughman J, Nolan JM, Beatty S. |
2012 |
| Education Is Positively Associated with Macular Pigment: The Irish Longitudinal Study on Ageing (TILDA) |
Nolan JM, Feeney J, Kenny RA, Cronin H, O'Regan C, Savva GM, Loughman J, Finucane C, Connolly E, Meagher K, Beatty S. |
2012 |
|
The impact of macular pigment augmentation on visual performance using different carotenoid formulations.
|
Loughman J, Nolan JM, Howard AN, Connolly E, Meagher K, Beatty S |
2012 |
|
Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration
|
Meagher KA, Thurnham DI, Beatty S, Howard AN, Connolly E, Cummins W, Nolan JM |
2012 |
| Amelioration of radiation induced damages in mice by carotenoid meso -zeaxanthin |
Alikkunjhi Pararikkal Firdous , Edakkadath Raghavan Sindhu , Viswanathan Ramnath and Ramadasan Kuttan |
2012 |
| Influence of the dietary carotenoids lutein and zeaxanthin on visual performance: application to baseball |
Hammond BR and Fletcher LM |
2012 |
| Lutein, zeaxanthin, meso-zeaxanthin content in egg yolk and their absence in fish and seafood |
Rasmussen HM, Muzhingi, T, Eggert, E.R, Johnson, EJ |
2012 |
| Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment |
Nolan JM, AkkalI MC, Loughman J, Howard A, Beatty S. |
2012 |
| A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration. |
Sabour-Pickett S, Nolan JM, Loughman J, Beatty S. |
2012 |
| Supplementation with all three macular carotenoids: response, stability and safety |
Connolly, E.E, Beatty, S, Loughman, J, Howard, A, Louw, M, Nolan, JM |
2011 |
| Macular pigment and its contribution to visual performance and experience |
James Loughmana,*, Peter A. Davisona, John M. Nolanb, M.C. Akkalib, Stephen Beattyb |
2010 |
| 26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: Evidence-based nutrition |
Biesalski HK, J Aggett P, Anton R, Bernstein PS, Blumberg J, Heaney RP, Henry J, Nolan JM, Richardson DP, van Ommen B, Witkamp RF, Rijkers G |
2010 |
| Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing. |
Nolan JM, Kenny R, O'Regan C, et al. |
2010 |
| Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study |
Connolly EE, Beatty S, Thurnham DI, et al |
2010 |
| A central dip in the macular pigment spatial profile is associated with age and smoking |
Kirby ML, Beatty S, Loane E, et al |
2010 |
|
Studies on the singlet oxygen scavenging mechanism of human macular pigment
|
Li B, Ahmed F, Bernstein PS |
2010 |
| Xanthophyll (lutein, zeaxanthin) content in fruits, vegetables and corn and egg products |
Perry A, Rasmussen H, Johnson EJ |
2009 |
| The rationale and evidence base for a protective role of macular pigment in age-related maculopathy |
Loane E, Kelliher C, Beatty S, Nolan JM |
2008 |
| A supplementation study in human subjects with a combination of meso-zeaxanthin, (3R,3'R)-zeaxanthin and (3R,3'R,6'R)-lutein. |
Thurnham DI, Tremel A, Howard AN. |
2008 |
| A review of dietary sources and bioavailability and some relationships with macular pigment optical |
Thurnham DI |
2007 |
| Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. |
Nolan JM, Stack J, O' DO, Loane E, Beatty S. |
2007 |
| Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula |
Bhosale P, Zhao dY, Serban B, Bernstein PS |
2007 |
| Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin |
Bone RA, Landrum JT, Cao Y, Howard AN, varez-Calderon F |
2007 |
| Salmonella-Escherichia coli/Mammalian-microsome reverse mutation assay with a confirmatory assay with mesozeaxanthin |
Mecchi MS |
2006 |
| Thirteen-week oral (gavage) toxicity of mesozeaxanthin in Han Wistar rats with a 4-week recovery |
Chang CJG |
2006 |
| Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation |
Bhosale P, Bernstein PS |
2005 |
| Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys |
Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM |
2005 |
| Identification and Characterization of a Pi Isoform of Glutathione S-Transferase (GSTP1) as a Zeaxanthin-binding Protein in the Macula of the Human Eye. |
Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS |
2004 |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. |
Kassoff A, The AREDS research group |
2001 |
| Stereochemistry of the Human Macular Carotenoids |
Bone RA, Landrum JT, Hime GW, Cains A, Zamor J |
1993 |
| The first isolation of enantiomeric and meso-zeaxanthin in nature |
Maoka T, Arai A, Shimizu M, Matsuno T |
1986 |
| The Macular Pigment .1. Absorbance Spectra, Localization, and Discrimination from Other Yellow Pigments in Primate Retinas |
Snodderly DM, Brown PK, Delori FC, Auran JD |
1984 |
|
OPTOMETRY PUBLICATIONS
|
|
|
|
Introduction of a Toric Intraocular Lens to a Non-Refractive Cataract Practice: Challenges and Outcomes
|
Clare Kirwan, John M Nolan, Jim Stack, Ian Dooley, Johnny Moore, Tara CB Moore, and Stephen Beatty |
2016 |
|
The Impact of Cataract, and Its Surgical Removal, on Measures of Macular Pigment Using the Heidelberg Spectralis HRAþOCT MultiColor Device
|
Kwadwo Owusu Akuffo, John M. Nolan, Jim Stack, Rebecca Power, Clare Kirwan, Rachel Moran,Laura Corcoran,Niamh Owens,and Stephen Beatty |
2016 |
| The eye-health diet |
Nolan J, Withers, N |
2012 |
| Impact of macular pigment on visual performance |
Dennison J, Nolan JM, Beatty S, O'Regan G |
2012 |
| Effect of Lutein and Zeaxanthin on Macular Pigment and Visual Function in Patients with Early Age-Related Macular Degeneration |
Le Ma, MD, Shao-Fang Yan, MD, Yang-Mu Huang, MD, Xin-Rong Lu, MsC Fang Qian, MsC, Hong-Lei Pang, MsC, Xian-Rong Xu, MD, Zhi-Yong Zou, MD, Pe |
2012 |
| The Heritability of Macular Response to Supplemental Lutein and Zeaxanthin: a Classical Twin Study. |
Hammond CJ, Liew SM, Van Kuijk FJ, Beatty S, Nolan JM, Spector TD, Gilbert C |
2012 |
| Targeting AMD with a Critical Carotenoid |
Bone R, Landrum J, Beatty S, Nolan JM |
2011 |
| Dietary macular carotenoid supplements and drusen resolution |
Asif F, Nolan JM |
2011 |
| Online AMD Research Study for Optometrists: Current Practice in the Republic of Ireland and the UK |
Loughman J, Nolan JM, Stack J, Beatty S. |
2011 |
| Macular supplements |
Loane E, Nolan JM, Baranyovits P, Akkali M, Beatty S |
2009 |
| Identifying and managing risk of AMD |
Nolan JM, Beatty S, O'Regan G |
2008 |
| Impact of macular pigment on visual performance |
Loughman J, Davison P, Nolan JM, Beatty S |
2007 |
| Macular pigment and its putative protective effect for ARM |
Kirby M, Loane E, Nolan JM, Beatty S |
2007 |